Skip to main content

Relationship between congenital anomalies and contraception

Advances in Contraception volume 1, pages 3–30 (1985)Cite this article

Abstract

Most contraceptive methods are associated with defined maternal risks. These risks can be balanced against the benefits, with individual users arriving at iformed decisions concerning propriety of using a given method. Physicians and patients alike have grown accustomed to benefits/risks analysis of this type.

More difficult to assess, however, would be fetal risks associated with contraceptive use. In the past decade, increasing attention has been given to allegations that various forms of contraception pose fetal risks. Sometimes risks are claimed as a result of exposure during pregnancy (teratogenesis). At other times long-term risks are claimed after discontinuation of the contraceptive agent. That is, there are risks due to exposure prior to pregnancy (mutagenesis).

In this communication we shall review the various allegations, attempt to define the more reasonable possibilities in order to suggest future studies assuring contraceptive safety, and provide information suitable for counseling of patients who inadvertently become pregnant while using contraception.

This is a preview of subscription content, access via your institution.

References

  1. SimpsonJ. L., GolbusM. S., MartinA. O. and SartoG. E. (1982).Genetics in Obstetrics and Gynecology. Grune & Stratton, New York

    Google Scholar 

  2. FraserF. C. and FainstatT. D. (1951). Production of congenital defects in the offspring of pregnant mice treated with cortisone.Pediatrics,8, 527

    PubMed  Google Scholar 

  3. PhelanM. C., PollockJ. M. and NanceW. E. (1982). Discordant expression of fetal hydantoin syndrome in heteroplacental dizygotic twins.N. Engl. J. Med.,307, 99

    PubMed  Google Scholar 

  4. Simpson, J. L. and Mills, J. L. (1985). Methodological problems in determining fetal loss rates: Relevance to chorionic villus sampling.Hum. Genet. (in press)

  5. SimpsonJ. L. (1984). Mutagenicity and teratogenicity of injectable and implantable progestins: probable lack of effect.Long Acting Steroidal Contraception, G. I.Zatuchni, et al. eds., Lippincott, Philadelphia, p. 334

    Google Scholar 

  6. SmithellsR. W. and ChenE. R. (1965). The problem of teratogenicity.Practitioner,198, 104

    Google Scholar 

  7. Rice-WrayE., CorrenS. and GastelumH. (1966). Erfahrungen mit dem oralen Kontrazeptivum Anovlar.Med. Klin.,61, 24

    Google Scholar 

  8. PetersonW. F. (1969). Pregnancy following oral contraceptive therapy.Obstet. Gynecol.,34, 363

    PubMed  Google Scholar 

  9. SpiraN., GoujardJ., HuelG. and Rumeau-RouquetteC. (1972). Etude teratogene des hormones sexuelles. Premiers resultats d'une enquete epidemiologique portant sur 20,000 femmes.Rev. Red. Fr.,41, 2683

    Google Scholar 

  10. HarlapS., PrywesR. and DaviesA. M. (1975). Birth defects and oestrogens and progesterones in pregnancy.Lancet,1, 682

    PubMed  Google Scholar 

  11. KullanderS. and KällenB. (1976). A prospective study of drugs and pregnancy.Acta Obstet. Gynecol. Scand.,55, 221

    PubMed  Google Scholar 

  12. Royal College of General Practitioners (1976). The outcome of pregnancy in former oral contraceptive users.Br. J. Obstet. Gynaecol.,83, 608

    Google Scholar 

  13. GoujardJ. and Rumeau-RouquetteC. (1977). First trimester exposure to progestagen/estrogen and congenital malformations.Lancet,1, 482

    PubMed  Google Scholar 

  14. HeinonenO. P., SloneD., MonsonR. R., HookE. B. and ShapiroS. (1976). Cardiovascular birth defects in antenatal exposure to female sex hormones.N. Engl. J. Med.,296, 67

    Google Scholar 

  15. HeinonenO. P., SloneD. and ShapiroS. (1977).Birth Defects and Drugs in Pregnancy. Pub. Sciences Group, Littleton, Mass.

    Google Scholar 

  16. NoraJ. J., NoraA. H., BlumJ., IngramJ., FountainA., PetersonM., LortscherR. H. and KimberlingW. J. (1978). Exogenous progestogen and estrogen implicated in birth defects.J. Am. Med. Assoc.,240, 837

    Google Scholar 

  17. TorfsC. P., MilkovichL. and Van DenBergB. J. (1981). The relatioship between hormonal pregnancy tests and congenital anomalies: a prospective study.Am. J. Epidemiol.,113, 563

    PubMed  Google Scholar 

  18. GoujardJ., Rumeau-RouquetteC. and Saurel-CubizallesM. J. (1979). Tests hormonaux de grossesse et malformations congenitales.J. Gynecol. Obstet. Repr.,8, 489

    Google Scholar 

  19. VesseyM. P. (1979). Outcome of pregnancy in women using different methods of contraception.Br. J. Obstet. Gynaecol.,86, 548

    PubMed  Google Scholar 

  20. SavolainenE., SakselaE. and SaxenL. (1981). Teratogenic hazards of oral contraceptives analyzed in a national malformation register.Am. J. Obstet. Gynecol.,140, 521

    PubMed  Google Scholar 

  21. MichaelisJ., MichaelisH., GluckE. and KollerS. (1983). Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations.Teratology,27, 57

    PubMed  Google Scholar 

  22. World Health Organization (1982). Facts about injectable contraceptives: Memorandum from a WHO meeting.Bull. WHO,60, 199

    Google Scholar 

  23. AarskogD. (1971). Maternal progestins as a possible cause of hypospadias.N. Engl. J. Med.,300, 75

    Google Scholar 

  24. MonteleoneR. N., CastillaE. E. and PazJ. E. (1981). Hypospadias: an epidemiologic study in Latin America.Am. J. Med. Genet.,10, 5

    PubMed  Google Scholar 

  25. CzeizelA., TothJ. and ErodiE. (1979). Aetiological studies of hypospadias in Hungary.Hum. Hered.,29, 166

    PubMed  Google Scholar 

  26. BrackenM. B., HolfordT. R., WhiteC. and KelseyJ. L. (1978). Role of oral contraception in congenital malformations of offspring.Int. J. Epidemiol.,7, 309

    PubMed  Google Scholar 

  27. SweetR. A., SchrootH. G., KurlandR. and CulpO. S. (1974). Study of the incidence of hypospadias in Rochester, Minnesota, 1940–1970, and a case-control comparison of possible etiologic factors.Mayo Clin. Proc.,49, 52

    PubMed  Google Scholar 

  28. AvellanL. (1977). On actiological factors in hypospadias.Scand. J. Plast. Reconstr. Surg.,11, 115

    PubMed  Google Scholar 

  29. LevyE. P., CohenA. and FraserF. C. (1973). Hormone treatment during pregnancy and congenital heart disease.Lancet,1, 611

    Google Scholar 

  30. Nora, J. J. and Nora, A. H. (1973). Preliminary evidence for a possible association between oral contraceptives and birth defects.Teratology,7, A24

    Google Scholar 

  31. JanerichD. T., DuganJ. M., StandfastS. J. and StritsL. (1977). Congenital heart disease and prenatal exposure to exogenous sex hormones.Br. Med. J.,1, 1058

    PubMed  Google Scholar 

  32. GreenbergG., InmanW. H. W., WeatherallJ. A. C., AdelsteinA. M. and HaskeyJ. C. (1977). Maternal drug histories and congenital abnormalities.Br. Med. J.,2, 853

    PubMed  Google Scholar 

  33. Mulvihill, J. J., Mulvihill, C. C. and Neill, C. A. (1976). Prenatal sex-hormone exposure and cardiac defects in man.Teratology,9, A30

    Google Scholar 

  34. YasudaM. and MillerJ. R. (1975). Prenatal exposure to oral contraceptives and transposition of the great vessels in man.Teratology,12, 239

    PubMed  Google Scholar 

  35. RothmanK. J., FylerD. C., GoldblattA. and KreidbergM. B. (1979). Exogenous hormones and other drug exposures of children with congenital heart disease.Am. J. Epidemiol.,169, 433

    Google Scholar 

  36. MatsunagaE. and ShiotoK. (1977). Threatened abortion, hormone therapy, and malformed embryos.Teratology,30, 469

    Google Scholar 

  37. JanerichD. T., PiperJ. M. and GlebatisD. M. (1974). Oral contraceptives and congenital limb-reduction defects.N. Engl. J. Med.,291, 697

    PubMed  Google Scholar 

  38. NishimuraH., UwabeC. and SembaR. (1974). Examination of teratogenicity of progestogens and/or estrogens by observation of the induced abortuses.Teratology,10, 93

    Google Scholar 

  39. CalI., KirmanB. and SternJ. (1967). Hormonal pregnancy tests and neural tube defects.Nature,216, 83

    Google Scholar 

  40. LaurenceM., MillerM., VowlesM., EvansK. and CarterC. (1971). Hormonal pregnancy tests and neural tube defects.Nature,233, 495

    Google Scholar 

  41. OakleyG. P., FlyntJ. W. and FalekA. (1973). Hormonal pregnancy tests and congenital malformations.Lancet,2, 256

    Google Scholar 

  42. HarlapS. and EldorJ. (1980). Births following oral contraceptive failure.Obstet. Gynecol.,55, 447

    PubMed  Google Scholar 

  43. NoraA. H. and NoraJ. J. (1975). A syndrome of multiple congenital anomalies associated with teratogenic exposure.Arch. Environ. Health,30, 17

    PubMed  Google Scholar 

  44. LorberC. A., CassidyS. B. and EngelE. (1979). Is there an embryo-fetal exogenous sex steroid exposure syndrome (EFESSES)?Fertil Steril.,31, 21

    PubMed  Google Scholar 

  45. DavidT. J. and O'CallaghanS. E. (1974). Birth defects and oral hormonal preparations.Lancet,1, 1238

    Google Scholar 

  46. WilsonJ. G. and BrentR. L. (1981). Are female sex hormones teratogenic?Am. J. Obstet. Gynecol.,141, 567

    PubMed  Google Scholar 

  47. World Health Organization (1981). The effect of female sex hormones on fetal development and infant health. World Health Organization (WHO) Technical Report Series 657. WHO, Geneva

    Google Scholar 

  48. GrayR. H. (1983). Progestins in therapy. Teratogenesis. In:Progestogens in Therapy, G.Benagiano et al., eds., Raven Press, New York, p. 109

    Google Scholar 

  49. LangR. and RedmanU. (1979). Non-mutagenicity of some sex hormones in the Ames salmonella/microsome mutagenicity test.Mutation Res. (Amsterdam),67, 361

    Google Scholar 

  50. CarrD. H. (1970). Chromosome studies in selected spontaneous abortions. 1. Conception after oral contraceptives.J. Can. Med. Assoc.,103, 343

    Google Scholar 

  51. BouéA. and BouéJ. (1973). Actions of steroid contraceptives on genetic material.Geburtsh. Frauenheilk.,32, 77

    Google Scholar 

  52. LauritsenJ. G. (1975). The significance of oral contraceptives in causing chromosome anomalies in spontaneous abortions.Acta Obstet. Gynecol. Scand.,64, 261

    Google Scholar 

  53. AlbermanE., CreasyM., ElliottM. and SpicerC. (1976). Maternal factors associated with fetal chromosomal anomalies in spontaneous abortions.Br. J. Obstet. Gynaecol.,83, 261

    Google Scholar 

  54. DhardialR. K., MachinA. M. and TaitS. M. (1971). Chromosome anomalies in spontaneously aborted human fetuses.Lancet,2, 20

    Google Scholar 

  55. KlingerH. P., GlaserM. and KavaH. W. (1976). Contraceptives and conceptus: 1. Chromosome abnormalities of the fetus and neonate related to maternal contraceptive history.Obstet. Gynecol.,48, 40

    PubMed  Google Scholar 

  56. BarrieH. (1976). Congenital malformation associated with intrauterine contraceptive device.Br. Med. J.,1, 488

    PubMed  Google Scholar 

  57. LeightonP. C., EvansD. G. and WallisS. M. (1976). IUD and congenital malformations,Br. Med. J.,1, 959

    Google Scholar 

  58. BarlowS. M. and KnightA. F. (1983). Teratogenic effects of Silastic intrauterine devices in the rat with or without added medroxprogesterone acetate.Fertil. Steril.,39, 224

    PubMed  Google Scholar 

  59. TatumH. J., SchmidtF. H. and JainA. K. (1976). Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device.Am. J. Obstet. Gynecol.,126, 869

    PubMed  Google Scholar 

  60. AlbertA. (1983). Study of pregnancies in women with intrauterine devices of copper.Reproduction,7, 35

    Google Scholar 

  61. SnowdenR. (1976). IUD and congenital malformation.Br. Med. J.,1, 770

    Google Scholar 

  62. GuillebaudJ. (1976). IUD and congenital malformations.Br. Med. J.,1, 1016

    Google Scholar 

  63. VesseyM., MeislerL. and FlavilR. (1979). Outcome of pregnancies in women using different methods of contraception.Br. J. Obstet. Gynaecol.,86, 548

    PubMed  Google Scholar 

  64. MishellD. (1978). Pregnancy-related complications and bleeding problems with IUDs. In.Risks, Benefits, and Controversies in Fertility Control, J. J.Sciarra et al., eds., Harper & Row, Hagerstown, p. 428

    Google Scholar 

  65. PerlmutterJ. F. (1978) Pregnancy and the intrauterine device.J. Reprod. Med.,20, 137

    Google Scholar 

  66. Stevens, J. D. and Fraser, I. S. (1974). The outcome of pregnancy after failure of an intrauterine contraceptive device.J. Obstet. Gynaecol. Br. Commonw., 282

  67. LaydeP. M., GoldbergM. F., SafraM. J. and OakleyG. P.Jr. (1979). Failed intrauterine device contraception and limb reduction deformities: a case control study.Fertil. Steril.,31, 18

    PubMed  Google Scholar 

  68. BrackenM. B. and VitaK. (1983). Frequency of non-hormonal contraception around conception and association with congenital malformations in offspring.Am. J. Epidemiol.,117, 281

    PubMed  Google Scholar 

  69. JickH., WalkerA. M., RothmanK. J., HunterJ. R., HolmesL. B., WatkinsR. N., D'EwartD. C., DanfordA. and MadsenS. (1981). Vaginal spermicides and congenital disorders.J. Am. Med. Assoc.,245, 1329

    Google Scholar 

  70. SmithE. S. O., DafoeC. S. and MillerJ. R. (1977). An epidemiological study of congenital reduction deformities of the limbs.Br. J. Prev. Soc. Med.,31, 39

    PubMed  Google Scholar 

  71. RothmanK. J. (1982). Spermicide use and Down's syndrome.Am. J. Publ. Health,72, 399

    Google Scholar 

  72. PolednakA. P., JanerichD. T. and GlebatisD. M. (1982). Birth weight and birth defects in relation to maternal spermicide use.Teratology,26, 27

    PubMed  Google Scholar 

  73. MillsJ. L., HarleyE. E., ReedG. F. and BerendesH. W. (1982). Are spermicides teratogenic?.J. Am. Med. Assoc.,248, 2148

    Google Scholar 

  74. CorderoJ. F. and LaydeP. M. (1983). Vaginal spermicides, chromosomal abnormalities and limb reduction defects.Fam. Plan. Perspect.,15, 16

    Google Scholar 

  75. ShapiroS., SloneD., HeinonenO. P., KaufmanD. W., RosenbergL., MitchellA. A., HelmrichS. P. (1982). Birth defects and vaginal spermicides.J. Am. Med. Assoc.,247, 2381.

    Google Scholar 

  76. HugginsG., VesseyM. and FlavilR. (1982). Vaginal spermicides and outcome of pregnancy: findings of a large cohort study.Contracepiton,25, 219

    Google Scholar 

  77. Mills, J. L., Reed, G. F., Nugent, R. P., Harley, E. E. and Berendes, H. W. (1985). Are there adverse effects of periconceptional spermicide use?Fertil. Steril. (in press)

  78. SchollT. O., SobelE., TanferK., SoeferE. F. and SaidmanB. (1983). Effects of vaginal spermicides on pregnancy outcome.Fam. Plan. Perspect.,15, 244

    Google Scholar 

  79. JickH., ShictaK., ShepardT. H., HunterJ., StergachisA., MadsenS. and PorterJ. B. (1979). Vaginal spermicides and miscarriage seen primarily in the emergency room.Teratogen. Carcinogen. Mutagen.,2, 205

    Google Scholar 

  80. SimpsonJ. L. (1978). Genetic consequences of aging sperm or aging ova: animal studies and relevance to humans. In:Risks, Benefits, and Controversies in Fertility Control, J. J.Sciarra et al., eds., Harper & Row, Hagerstown, p. 506

    Google Scholar 

  81. SoderwallA. L. and BlandauR. J. (1941). The duration of the fertilizing capacity of spermatozoa in the female genital tract of the rat.J. Exp. Zool.,88, 55

    Google Scholar 

  82. SoderwallA. L. and YoungW. C. (1940). Effect of aging in the female genital tract on the fertilizing capacity of guinea pig spermatozoa.Anat. Rec.,78, 19

    Google Scholar 

  83. MartinP. A. and ShaverE. L. (1972).Sperm aging in utero and chromosomal anomalies in rabbit blastocysts.Dev. Biol.,28, 480

    PubMed  Google Scholar 

  84. YoungW. C. (1929). A study of the function of the epididymis. II. The importance of an aging process in sperm for the length of the period during which fertilizing capacity is retained by sperm isolated in the epididymis of the guinea pig.J. Morphol. Physiol.,48, 475

    Google Scholar 

  85. TeshJ. M. and GloverT. D. (1969). Aging of rabbit spermatozea in the male tract and its effects on fertility,J. Reprod. Fertil.,20, 287

    PubMed  Google Scholar 

  86. Martin-De LeonP. A., ShaverE. L. and GammalE. B. (1973). Chromosome abnormalities in rabbit blastocysts resulting from spermatozoa aged in the male tract.Fertil. Steril.,24, 212

    PubMed  Google Scholar 

  87. Martin-De LeonP. A. and BoiceM. L. (1982). Sperm aging in the male and cytogenetic anomalies: an animal model.Hum. Genet.,62, 70

    PubMed  Google Scholar 

  88. PflügerE. (1882). Versuche der Befruchtung überreifer.Arch. Ges. Physiol.,26, 76

    Google Scholar 

  89. WitschiE. (1952). Overripeness of the eggs as a cause of twinning and teratogenesis. A review.Cancer Res.,12, 763.

    PubMed  Google Scholar 

  90. WitschiE. and LaguensR. (1963). Chromosomal aberrations in embryos from overripe eggs.Dev. Biol.,7, 605

    PubMed  Google Scholar 

  91. ChangM. C. and HuntD. M. (1968). Attempts to induce polyspermy in the rabbit by delayed insemination and treatment with progesterone.J. Exp. Zool.,167, 419

    PubMed  Google Scholar 

  92. ThibaultC. (1967). Analyse comparée de la fécondation et de ses anomalies chez la brebis la vache et la lapine.Ann. Biol. Anim. Biochem. Biophys.,7, 5

    Google Scholar 

  93. ShaverE. L. and CarrD. H. (1969). The chromosome complement of rabbit blastocysts in relation to the time of mating and ovulation.Can. J. Genet. Cytol.,11, 287

    PubMed  Google Scholar 

  94. AustinC. R. (1967). Chromosome deterioration in aging eggs of the rabbit.Nature (Lond.),213, 1018

    Google Scholar 

  95. BlandauR. J. and JordanE. S. (1941). The effects of delayed fertilization on the development of the rat ovum.Am. J. Anat.,68, 275

    Google Scholar 

  96. SoderwallA. L. and BlandauR. J. (1941). The duration of the fertilizing capacity of spermatozoa in the female genital tract of the rat.J. Exp. Zool.,88, 55

    Google Scholar 

  97. VickersA. D. (1969). Delayed fertilization and chromosomal anomalies in mouse embryos.J. Reprod. Fertil.,20, 69

    PubMed  Google Scholar 

  98. DonahueR. P. (1975). Normal and abnormal chromosomal behavior in the meiotic divisions of mammalian oocytes. In:Aging Gametes: Their Biology and Physiology, S. Karger, Basel

    Google Scholar 

  99. YoungR. J. and BlandauR. J. (1936). Ovum age and the course of gestation in the guinea pig.Science,84, 270

    Google Scholar 

  100. HancockJ. L. (1959). Polyspermy of pig ova.Vet. Res.,70, 1200

    Google Scholar 

  101. YamamotoM. and IngallsT. H. (1972). Delayed fertilization and chromosomal anomalies in the hamster embryo.Science,176, 518

    PubMed  Google Scholar 

  102. GermanJ. (1968). Mongolism, delayed fertilization, and human sexual behaviour.Nature (Lond.),217, 516

    Google Scholar 

  103. ShokierM. (1968). Coital frequency and Down's syndrome.Lancet,2, 1081

    Google Scholar 

  104. JongbloetP. H. (1968). Overripeness of the egg. Consideration of the etiology of Goldenhar's syndrome and related congenital dysplasias including chromosomal aberrations.Maandschr. Kindergeneeskd.,36, 352

    Google Scholar 

  105. JongbloetP. H. (1969). The intriguing phenomenon of gametopathy and its disastrous effects on the human progeny.Maandschr. Kindergeneeskd.,37, 261

    Google Scholar 

  106. JongbloetP. H. (1975). The effects of pre-ovulatory overripeness of human eggs on development. In.Aging Gametes: Their Biology and Physiology, S. Karger, Basel

    Google Scholar 

  107. JongbloetP. H. and ZwetsJ. H. J. (1976). Pre-ovulatory overripeness of the egg in the human subject.Int. J. Gynaecol. Obstet.,14, 111

    PubMed  Google Scholar 

  108. JongbloetP. H. and VanErkelens-ZwetsJ. H. J. (1978). Rhythm methods: are there risks to the progeny? In:Risks, Benefits, and Coniroversies in Fertility Control, J. J.Sciarra et al., eds., Harper & Row, Hagerstown, p. 520

    Google Scholar 

  109. Milstein-MoscatiI. and BecakW. (1981). Occurrence of Down's syndrome and human sexual behavior.Am. J. Med. Genet.,9, 211

    PubMed  Google Scholar 

  110. GuerreroR. and RojasO. I. (1975). Spontaneous abortion and aging of human eva and spermatozoa,N. Engl. J. Med.,293, 573

    PubMed  Google Scholar 

  111. JamesW. H. (1968). Mongolism, delayed fertilization and sexual behaviour.Nature (Lond.),219, 279

    Google Scholar 

  112. HansmannI. (1983). Factors and mechanisms involved in nondisjunction and X-chromosome loss. In.The Cytogenetics of the Mammalian X-chromosome, A.Sandberg, ed., Liss, New York, p. 131

    Google Scholar 

Download references

Author information

Affiliations

  1. Northwestern University Medical School, 333 E. Superior Street, 60611, Chicago, IL, USA

    J. L. Simpson

Authors
  1. J. L. Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Simpson, J.L. Relationship between congenital anomalies and contraception. Adv Contracept 1, 3–30 (1985). https://doi.org/10.1007/BF01849140

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01849140

Keywords

  • Public Health
  • Future Study
  • Congenital Anomaly
  • Contraceptive Method
  • Individual User